FDA Must Protect Women and Children From Dangerous Abortion Drugs
Liberty Counsel filed an amicus brief to the U.S. Fifth Circuit Court of Appeals in Louisiana v. FDA, a case seeking to reinstate the in-person dispensing requirement for the chemical abortion drug Mifepristone. In 2023, the U.S. Food and Drug…









